Pylarify Coupon & Prices
Get notified when Pylarify medication is added to NiceRxGet Started Now
Secure: Your personal and medical information is safe with us
Convenient: Your medication is delivered straight to your door
Ongoing refills: Your medication is refilled automatically
Is NiceRx a Pylarify coupon provider?
NiceRx is not a Pylarify coupon, Pylarify discount card, or Pylarify copay card provider. We do not offer Pylarify manufacturer coupons, Pylarify discounts, rebates, Pylarify savings cards, trial offers, or free Pylarify samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Pylarify patient assistance program
Patient assistance programs are typically sponsored by pharmaceutical companies and provide free or discounted medications to individuals with low income who are uninsured or under-insured and meet the eligibility criteria that vary by program. There are currently no known patient assistance programs for this medication.
Can NiceRx help me get Pylarify cheaper if I have insurance?
How much does Pylarify cost without insurance?
Without insurance, Pylarify costs will vary depending on where you buy the medication as prices will vary by retailer.
How much does Pylarify cost with insurance?
The copay for Pylarify will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Pylarify?
Pylarify is a prescription medication manufactured by Progenics Pharmaceuticals, Inc., a Lantheus Holdings, Inc., company. The FDA (U.S. Food and Drug Administration) has approved Pylarify a radiopharmaceutical drug for positron emission tomography (PET/CT imaging) of prostate-specific membrane antigen (PSMA) positive lesions in prostate cancer patients who are candidates for initial definitive therapy to identify suspected metastasis or recurrence of prostate cancer, as well as to identify tumors in the lymph nodes, bones, and other organs.
FDA approval of Pylarify is based on data from studies (Osprey and Condor) designed to establish the safety and diagnostic performance of Pylarify for the treatment of prostate cancer. Results from the Osprey study showed an improvement in specificity and positive predictive value (PPV) of Pylarify PET imaging over conventional imaging in men at risk for metastatic prostate cancer cells prior to initial treatment. From the Condor study of patients with biochemical recurrent prostate cancer and non-informative baseline imaging, Pylarify showed high correct localization and rates of detection, including those patients with low PSA values.
What doses of Pylarify are available?
Pylarify is available in injection form, in the following doses: 37 MBq/mL to 2,960 MBq/mL (1 mCi/mL to 80 mCi/mL) at calibration date and time.
There is a risk of image misinterpretation, and Pylarify uptake can also be seen in a number of different tumor types as well as in non-cancerous processes and normal tissues. Please see the full prescribing information and always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Pylarify active ingredients
The active ingredient of Pylarify is piflufolastat F 18, a PSMA-targeted PET imaging agent.
Pylarify side effects
The most common side effects of Pylarify in clinical trials include:
In rare instances, Pylarify can cause more serious side effects. These can include:
- Hypersensitivity reactions
- Radiation risk
Your doctor will assess the benefits of using Pylarify against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Pylarify to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Pylarify drug interactions
Other drugs may interact with Pylarify, including prescription drugs and over-the-counter medicines, vitamins, and herbal products. Tell your health care provider about all of your medications including any supplements you are taking.
You should not use Pylarify if you:
- Are allergic to the active ingredient piflufolastat F 18
- Are allergic to any of the other ingredients in Pylarify
Talk to your doctor before using Pylarify if you:
- Are taking any of the medications that could interact with Pylarify
- Are pregnant or are planning to become pregnant
- Are breastfeeding or are planning to breastfeed
Pylarify is the trademark brand name for piflufolastat F 18 manufactured by Progenics Pharmaceuticals, Inc. A generic version of piflufolastat F 18 is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Pylarify savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.